Gilead

Analyzing The Hepatitis C Market Size: Why It May Have Bullish Implications For Gilead
Seeking Alpha
Mon, 06/23/14 - 06:22 pm
Gilead
Sovaldi
hepatitis C
Medicare opens door wide for Gilead's $84K hep C drug Sovaldi
Fierce Pharma
Wed, 06/4/14 - 03:14 pm
Medicare
Gilead
hepatitis C
Sovaldi
Will Merck & Co. Inc Unseat Biotech's Hottest Drug?
Motley Fool
Fri, 04/18/14 - 11:42 am
Merck
MK-5172
MK-8742
Sovaldi
Gilead
hepatitis C
England agrees funding for Gilead hepatitis C drug
Yahoo/Reuters
Thu, 04/17/14 - 12:10 pm
England
Gilead
hepatitis C
Sovaldi
Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill
Bloomberg
Thu, 04/10/14 - 07:39 am
Merck
Gilead
hepatitis C
MK-5172
MK-8742
Sovaldi
The Hunt For Hidden Value: Gilead Gilded In Gold
Seeking Alpha
Tue, 04/1/14 - 08:59 am
Gilead
Sovaldi
Gilead says payers feel comfortable with the cost of Sovaldi
Fierce Pharma
Fri, 02/14/14 - 12:59 pm
Gilead
Sovaldi
insurance
hepatitis C
Gilead Hepatitis C Pill Leads 27 New U.S. Drug Approvals
Bloomberg
Wed, 01/1/14 - 11:02 am
Gilead
hepatitis C
drug approvals
Sovaldi
Can Gilead's $1,000 Pill Eradicate Hepatitis C?
Forbes
Thu, 12/19/13 - 11:35 am
Gilead
hepatitis C
Sovaldi
ledipasvir
FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen; Also Approved by European Commission
Benzinga
Fri, 12/13/13 - 04:50 pm
HIV
FDA
Gilead
Complera
Europe
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
3 Biopharmas Hoping for Good News From the FDA
Motley Fool
Wed, 12/4/13 - 03:45 pm
FDA
Auxilium
Xiaflex
Gilead
sofosbuvir
GSK
Theravance
Anoro Ellipta
Idenix fires off a shot in patent battle over Gilead's sofosbuvir
Fierce Biotech
Mon, 12/2/13 - 05:04 pm
Idenix
Gilead
sofosbuvir
hepatitis C
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Four Biotech 'Surprise' Stocks for 2014
TheStreet.com
Wed, 11/27/13 - 08:34 am
Seattle Genetics
Adcetris
Cubist Pharmaceuticals
Cempra
Eylea
Regeneron
Pharmacyclics
Imbruvica
Gilead
sofosbuvir
4 Biotech Stocks With Upcoming FDA Decision Dates
Seeking Alpha
Mon, 11/25/13 - 10:22 am
FDA
Gilead
Auxilium
GSK
Theravance
sofosbuvir
Xiaflex
Anoro
The Four Horseman of Pharma
CNBC
Sat, 11/23/13 - 12:36 pm
Gilead
Biogen Idec
Celgene
Regeneron
Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study
Yahoo
Mon, 11/18/13 - 10:28 am
Gilead
Idelalisib
CLL
chronic lymphocytic leukemia
Gilead Vs. Challengers In The Hepatitis C Race
Seeking Alpha
Thu, 11/7/13 - 09:52 am
Gilead
hepatitis C
AbbVie
Bristol-Myers Squibb
JNJ
Merck
simeprevir
sofosbuvir
daclatasvir
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Roche
Amgen
Gilead
Sanofi
Celgene

Pages